Ron Adar / Shutterstock.com
The incoming US presidential administration has made it clear that it will prioritise trade policy and undo a number of Trump’s decisions in this area, which could lead to significant ramifications for IP. Michael Nesheiwat and Jess Collen of law firm Collen IP report.
Despite the flurry of lawsuits and other legal challenges raised by President Donald Trump and his team over the past few weeks, it is inevitable that President-elect Joe Biden will become the next president of the US on inauguration day, January 20, 2021.
The Biden team has made it clear that it intends to undo or reverse a number of decisions and policy positions taken by Trump over the last four years. The new administration will have its work cut out for it upon taking office, most notably the COVID-19 crisis and the resulting economic fallout still plaguing the country. But one area that will surely be addressed—and where the differences with the Trump administration may be most pronounced—is trade policy.
It is also likely that the international harmonisation of IP rights will be addressed by the Biden administration, as the US has woven this issue into previous trade negotiations.
The rest of this article is locked for subscribers only. Please login to continue reading.
If you don't have a login, you will need to purchase a subscription to gain access to this article, including all our online content. Please use this link and follow the steps.
For multi-user price options, or to check if your company has an existing subscription to us that we can add you to for FREE, please email Atif Choudhury at achoudhury@worldipreview.com
Joe Biden, Collen IP, Donald Trump, COVID-19, trade policy, IP rights, TTP, RCEP, geographic indications, copyright, patent protection, pharmaceuticals
